Pioglitazone is superior to glimepiride at reducing carotid intima media thickness progression in type 2 diabetes mellitus

Author：

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1564, 2006-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone slows progression of CIMT in type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Common Carotid Artery Intima-media Thickness is not Increased but Distensibility is Reduced in Normotensive Patients with Type 2 Diabetes compared with Control Subjects

By Charvat J Chlumsky J Zakovicova E Kvapil M

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 860-869

Field House Publishing

Access to resources Recommend Favorite

Pioglitazone pays dividends in type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pioglitazone pays dividends in type 2 diabetes mellitus

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Glimepiride: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Langtry H.D. Balfour J.A.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 563-584

Adis International

Access to resources Recommend Favorite